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Abstract
Background: We sought to investigate the profile of symptoms and results of investigations among
six cases of suspected arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D).
Methods: The diagnosis of ARVC/D was made on the basis of standardised diagnostic
criteria proposed by the study group on ARVC/D of the European Society of Cardiology.
A study was conducted involving six patients with suspected ARVC/D that were diagnosed and
treated at our centre in the years 1992–2004.
Results: All patients presented with a typical history and with similar complaints and symp-
toms: limitation of exercise toleration, palpitations, dizziness, presyncope and syncope. In all
six cases ECG abnormalities were detected, namely T wave inversion, prolonged QRS com-
plexes in V1–V3 or/and epsilon waves. Echocardiographic abnormalities were also detected in
all cases in the form of global or segmental dilation and a reduction in right ventricular
ejection fraction, morphological irregularity of the endocardium and tricuspidal valve insuffi-
ciency. On the basis of diagnostic criteria we diagnosed ARVC/D in four cases and the
borderline variant of ARVC/D in the remaining two.
Conclusions: ARVC/D is a heart muscle disease with varied and complex presentation. The
profile of symptoms and the results of investigations and diagnostic procedures are varied and
can assume various combinations. Accurate diagnosis can be established in most cases as
a result of the non-invasive and widely-used techniques of ECG, 24-hour Holter monitoring
and echocardiography. (Cardiol J 2007; 14: 396–401)
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Introduction
Arrhythmogenic right ventricular cardiomyo-
pathy/dysplasia (ARVC/D) is a primary myocardial
disease [1] characterised by a generalised or
focused right ventricular myocytes replacement by
fibrous-fatty tissue [2, 3]. Secondary ARVC/D can
progress to left ventricular involvement and may
culminate in biventricular heart failure. The most
common clinical presentation of this irregularity,
which most commonly prevails among people
under 35 years of age and athletes, is of life-threat-
ening ventricular and supraventricular arrhythmias.
Monomorphic tachycardia was detected in all our cas-
es with left bundle branch block (LBBB). In 7–29%
of patients the first manifestation of disease is sud-
den cardiac death [4]. The diagnosis of ARVC/D
must be considered when a young, otherwise
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healthy, person complains of dizziness, palpitations,
presyncope or syncope, which characteristically
occur during exercise, or in a patient who presents
with syncope who has a family history of ARVC/D.
A number of cases are not recognised because
they are often, especially at the beginning, asympto-
matic or difficult to diagnose with conventional meth-
ods. With regard to this, a prospective investigation
on sudden cardiac death in Italy revealed that over
20% of fatal events in young people and over 25% of
fatalities in athletes were caused by ARVC/D [2–4].
A genetic background has been demonstrated
in 30–50% cases [5]. The disease is typically inher-
ited as an autosomal dominant trait with variable
penetration and incomplete expression. Most of the
genes identified code desmosomal family proteins
with a remarkably predominant yield of plakophilin-
2 mutations [6, 7]. Recently plakoglobin has been
identified as the first gene responsible for the au-
tosomal recessive variant of the disease (the so-
called “Naxos disease”) [8, 9]. In the remaining
sporadic cases a variety of etiologies is being con-
sidered. Among the theories explaining the transdif-
ferentiation of myocytes in fibrous-fatty tissue are
the inflammatory theory, which maintains that the
disease results from myocarditis, the degenerative
hypothesis, which holds that myocyte death is
a consequence of inherited metabolic or ultrastruc-
tural defect, and the apoptotic hypothesis, which is
supported by the high level of CPP-32, a cysteine
protease required for apoptosis [2, 10, 11].
In diagnosing ARVC/D, apart from the presen-
tation of the complaint and the family history re-
ferred to above, characteristic abnormalities in
ECG, Holter monitoring, echocardiography, late
potential analysis, computerised tomography, mag-
netic resonance imaging (MRI), electrophysiologi-
cal examination and endomyocardial biopsy [1–4]
are all very helpful.
Methods
Objective
We sought to investigate the profile of symptoms
as well as the results of investigations and diagnostic
procedures among people with suspected ARVC/D.
Diagnostic criteria of arrhythmogenic
right ventricular cardiomyopathy/dysplasia
Standardised diagnostic criteria have been pro-
posed by the study group on ARVC/D of the Europe-
an Society of Cardiology and by the International So-
ciety and Federation of Cardiology. According to the
task force guidelines, the diagnosis of ARVC/D is
based on the presence of major and minor criteria
encompassing genetic, ECG, arrhythmic, morpho-
functional and histopathological factors (Table 1) [12].
On the basis of this classification a diagnosis of
ARVC/D would be certain in the presence of two major
criteria, one major plus two minor or four minor cri-
teria from different groups. The presence of one ma-
jor plus one minor or three minor criteria is the basis
for diagnosing the borderline variant of ARVC/D.
Methods
A study was conducted involving six patients
(three women and three men) with suspected
ARVC/D, diagnosed and treated at our centre
(2nd Chair and Department of Cardiology, Medical Uni-
versity of Łódź) in the years 1992–2004. The group
ranged from 25 to 60 years (with a mean of 37 years).
The following data were recorded:
— detailed description of the presentation of the
complaint: dizziness, palpitations, presyncope,
syncope, stenocardia, limitation of exercise
toleration, family history;
— ECG: repolarisation and depolarisation abnor-
malities;
— echocardiography: all patients were investigat-
ed with transthoracic echocardiography with
classical projection. The morphology and meas-
urements of the right and left ventricles and
the flow with colour Doppler were assessed.
We looked for right ventricular segmental or
regional dilatation, aneurysms or morphologi-
cal abnormalities;
— exercise test and 24-hour Holter monitoring
with late potentials analysis;
— MRI (only carried out in one case);
— invasive diagnostic methods: coronary angiogra-
phy, endomyocardial biopsy and electrophysiolog-
ical research, depending on clinical indications.
Results
All patients presented with a typical history of
limitation of exercise toleration, palpitations, dizzi-
ness, presyncope and syncope. In one patient the his-
tory revealed sudden cardiac arrest in the mechanism
of ventricular fibrillation (documented), while in an-
other patient there was evidence of ARVC/D in the
family history (sudden cardiac death in his brother due
to ARVC/D, diagnosed post mortem at autopsy).
ECG abnormalities were detected in all cases:
— T wave inversion in the precordial leads explor-
ing the right ventricle V1–V3 in four patients
(Fig. 1);
— epsilon wave in one patient;
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— prolonged QRS complex to more than 110 ms
in the V1–V3 leads in one patient.
In one of the recorded ECGs we documented
ventricular arrhythmia (bigeminy) but not the
LBBB type, while in another ECG atrial fibrillation
was apparent.
In 24-hour Holter monitoring we observed re-
peated supraventricular tachycardia in four of our pa-
tients and ventricular arrhythmias, ranging from iso-
lated premature ventricular beats (Lown II, III or IVa)
to non-sustained and sustained ventricular tachycar-
dia with an LBBB morphology, in four patients (Lown
IVB). Late potentials were detected in two patients.
Echocardiographical abnormalities were detect-
ed in all our cases in the form of global or segmental
dilatation and a reduction in right ventricular ejec-
tion fraction, morphological irregularity of the en-
docardium (moderator band hyper-reflectivity or
trabecular derangement) or tricuspidal valve insuf-
ficiency (I–II°) (Fig. 2–4).
Results were obtained for only one ventriculog-
raphy, showing dilatation of the right ventricle with
enhanced trabeculosis, two endomyocardial biopsies,
showing fibrous-fatty replacement with degeneration
of the myocytes, and one MRI result, which showed
a dilated right ventricle with a lighter signal (indica-
tive of fat) from the free wall (Table 2).
Table 1. Criteria for diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Major criteria Minor criteria
I. Global or regional dysfunction Severe dilation and reduction of Mild global RV dilation or
and structural alterations RV ejection fraction; localised RV ejection reduction with normal LV;
aneurysms (akinetic or dyskinetic  regional RV hypokinesis
areas with diastolic bulging)
II. Tissue characterisation of Fibrous-fatty replacement of
walls  myocardium on endomyocardial biopsy
III. Repolarisation abnormalities Inverted T waves in right
precordial leads V2–V3
(people aged over 12 years;
in absence of RBBB
IV. Depolarisation abnormalities Epsilon waves or localised Late potentials
prolongation (> 110 ms) of
the QRS complex in right
precordial leads V1–V3)
V. Arrhythmia Left bundle branch block type
ventricular tachycardia (ECG, Holter,
exercise testing); frequent
ventricular extrasystoles more
than 1000/24 h in Holter
VI. Family history Familial disease confirmed at Familial history of premature
necropsy or surgery  sudden death (< 35 year) or clinical
 diagnosis based on present criteria
RV — right ventricle, LV — left ventricle, RBBB — right bundle branch block
Figure 1. ECG — precordial leads. Repolarisation
abnormalities — inverted T waves in right precordial
leads V2–V3.
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Discussion
The study is a presentation of six clinical cases
with ARVC/D diagnosed on the basis of the criteria
proposed by the study group on ARVC/D of the
European Society of Cardiology and by the Inter-
national Society and Federation of Cardiology [11].
The disease may be suspected on the basis of a typ-
ical history and physical examination. In most cas-
es we receive confirmation of the underlying pathol-
ogy without MRI or invasive testing such as en-
domyocardial biopsy, which involves a high risk of
complications.
The ECG abnormalities typical for ARVC/D,
mostly fulfilling minor diagnostic criteria, were de-
tected in all our cases in ECG and 24-hour Holter
monitoring. Despite its low sensitivity and specifi-
city ECG abnormalities are present in up to 90% of
Figure 2. Transthoracic two-dimensional echocardio-
gram recorded in a patient with arrhythmogenic
right ventricular cardiomyopathy/dysplasia. Parasternal
long-axis view showing dilation of the right ventricle;
RV — right ventricle, LV — left ventricle, LA — left
atrium, Ao — aorta.
Table 2. Summary of recorded data of the six analysed cases.
Patient ECG ECG ECHO Endo-myocardial NMR Lown Familial
(depolarisation (repolarisation biopsy score history
abnormalities) abnormalities) (IVB)
1 – + ++ ND ND – –
2 + – ++ ND ND – –
3 – + + ++ ND + –
4 ++ – + ND ++ + –
5 ++ + + ND ND + ++
6 + + ++ ++ ND + –
+: abnormalities fulfilled minor diagnostic criteria; ++: abnormalities fulfilled major diagnostic criteria; ND — not done
Figure 4. Transthoracic two-dimensional echocardio-
gram recorded in a patient with arrhythmogenic right
ventricular cardiomyopathy/dysplasia. An apical modi-
fied four-chamber view, showing dilation of the right
ventricle and marked thickening of the moderator band
(arrows); RV — right ventricle, LV — left ventricle, LA —
left atrium, RA — right atrium.
Figure 3. Transthoracic two-dimensional echocardio-
gram recorded in a patient with arrhythmogenic right
ventricular cardiomyopathy/dysplasia. An apical four-
-chamber view showing dilation of the right ventricle
and right atrium; RV — right ventricle, LV — left ventric-
le, LA — left atrium, RA — right atrium.
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ARVC/D patients [13, 14]. The most common ab-
normality consists of T wave inversion, often asso-
ciated with a slight ST-segment elevation < 0.1 mV,
in the precordial leads V1–V3 exploring the right
ventricle. These repolarisation changes, detected
in four of our patients, may be a normal variant in
children aged below 12 years or may be secondary
to a right bundle branch block. Relatively the most
sensitive and ARVC/D-specific ECG diagnostic
markers are epsilon waves (post-excitation poten-
tials of small amplitude that occur at the end of QRS
complex found in up to 30% of cases of ARVC/D)
and localised prolongation of the QRS complex in
V1–V3 to more than 110 ms (found in up to 60% of
cases of ARVC/D) [2, 3, 13]. These abnormalities
were observed in two of the cases analysed.
Another very helpful and useful method of
diagnosing ARVC/D is echocardiography. This tech-
nique, which is non-invasive, widely available, low
in cost and easy to perform and  interpret, has
played a crucial role in imaging structural and func-
tional abnormalities of the right ventricle. Gener-
ally, these irregularities in ARVC/D are moderate
and easily overlooked, which is why right ventricle
function should be measured at several points, in-
cluding the inflow and outflow tract, because of the
focal nature of the disease [15]. The development
of new echocardiographic techniques such as three-
dimensional, harmonic imaging and tissue echo
Doppler will minimise the number of false negative
results [14]. The echocardiographic findings most
suggestive of ARVC/D include dilatation of the right
ventricle with localised aneurysms and dyskinesis
in the inferior basal region [14, 15]. Right ventricle
end diastolic and end systolic diameter is another
very useful echocardiographic parameter in estab-
lishing the diagnosis of ARVC/D, as well as the ratio
of the right to left ventricle end diastolic diameters
(a ratio > 0.5 for the right ventricle/left ventricle end
diastolic diameter has a sensitivity of 86% and a spe-
cificity of 93% for the diagnosis of ARVC/D) [16].
There are numerous reports of the use of echocar-
diography to aid diagnosis of ARVC/D. These stud-
ies have found that the presence of right ventricular
dysfunction by two-dimensional echocardiography
had a high specificity and predictive value for ARVC/D
[15, 17, 18]. Echocardiographical abnormalities,
fulfilling major or minor diagnostic criteria, were
detected in all our cases.
Magnetic resonance imaging has recently been
added to the techniques used to diagnose ARVC/D.
It is a potentially useful test because it can distin-
guish fat from muscle. Cine MRI also provides
a good contrast between the blood and the myocar-
dial wall and can, therefore, provide information
about right ventricular motion and function. On the
other hand MRI does not improve on echocardiog-
raphy in revealing morphological and functional
changes in the right ventricle, whereas adipose tis-
sue detection is usually uncertain and cannot claim
to be one of the diagnostic criteria [19, 20]. A de-
finitive diagnosis of ARVC/D relies on the histolog-
ical demonstration of substitution of the right ven-
tricular myocardium by fatty or fibrous-fatty tissue
at endomyocardial biopsy (or autopsy in post-mor-
tem examination), although its sensitivity and
specificity is low owing to the segmental nature of
the ARVC/D lesions and difficulty in differentiat-
ing ARVC/D from other causes of fatty infiltration
of the right ventricular myocardium [21]. Because
an accurate diagnosis had been made earlier which
met standardised diagnostic criteria, and in view
of lack of availability and the high cost, we per-
formed only one MRI examination. In one patient
we established the diagnosis of ARVC/D on the
basis of an invasive diagnostic method, namely en-
domycardial biopsy (the result of another biopsy was
only a confirmation of the accuracy of the diagnosis
made earlier).
In summary, on the basis of diagnostic crite-
ria, we diagnosed ARVC/D in four cases and the
borderline variant of ARVC/D in the remaining two.
Conclusions
Arrhythmogenic right ventricular cardiomyop-
athy/dysplasia is a heart muscle disease with a high-
ly unspecified presentation. The profile of symp-
toms and investigation results are varied and can
assume different combinations. In most of the cas-
es presented we made an accurate diagnosis of
ARVC/D on the basis of echocardiographic and ECG
abnormalities, fulfilling the major or/and minor
European Society of Cardiology and the Internation-
al Society and Federation of Cardiology diagnostic
criteria.
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